Skip to main content
Top
Published in: Critical Care 4/2005

Open Access 01-08-2005 | Research

Time course of endothelial damage in septic shock: prediction of outcome

Authors: Ortrud Vargas Hein, Klaudia Misterek, Jan-Peer Tessmann, Vera van Dossow, Michael Krimphove, Claudia Spies

Published in: Critical Care | Issue 4/2005

Login to get access

Abstract

Introduction

Endothelial damage accounts greatly for the high mortality in septic shock. Higher expression of mediators (IL-6, IL-8, soluble intercellular adhesion molecule 1 [sICAM-1], soluble endothelial-linked adhesion molecule 1 [sELAM-1]) have been described for non-survivors in comparison with survivors. We investigated the predictive value of the mediators IL-6, IL-8, sELAM-1 and sICAM-1 and their time course in intensive care unit patients who developed septic shock with respect to outcome.

Materials and methods

We measured serum levels of IL-6, IL-8, sELAM-1 and sICAM-1 in 40 intensive care unit patients who developed septic shock. Measurements were performed until death or until resolution of septic shock. Clinical and laboratory data were also recorded.

Results

After 48 hours the levels of sELAM-1 and sICAM-1 increased in non-survivors and decreased in survivors. sELAM-1 was predictive for outcome on the third day (P = 0.02) and the fourth day (P = 0.02) after diagnosis of septic shock. This difference in the time course between survivors and non-survivors occurred 7 days before death of the patients (median, 10 days). sICAM-1 levels increased significantly in non-survivors over the study period (P < 0.001). sELAM-1 (P = 0.04), IL-6 (P = 0.04) and IL-8 (P = 0.008) were significantly higher in non-survivors over the whole study period. The age and norepinephrine dose >0.5 μg/kg/min were significantly different between the groups.

Conclusion

sELAM-1 showed a markedly opposing course after 48 hours of septic shock. This adhesion molecule may be a useful early predictor of disease severity in the course of septic shock after early initial treatment of the patients, and might suggest considering endothelial-restoring therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Peters K, Unger RE, Brunner J, Kirkpatrick CJ: Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003, 60: 49-57. 10.1016/S0008-6363(03)00397-3CrossRefPubMed Peters K, Unger RE, Brunner J, Kirkpatrick CJ: Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003, 60: 49-57. 10.1016/S0008-6363(03)00397-3CrossRefPubMed
2.
go back to reference Reinhart K, Bayer O, Brunkhorst F, Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002, 30: S302-S312. 10.1097/00003246-200205001-00021CrossRefPubMed Reinhart K, Bayer O, Brunkhorst F, Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002, 30: S302-S312. 10.1097/00003246-200205001-00021CrossRefPubMed
3.
go back to reference Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, Wakabayashi G, Niimi M, Taniguchi S, Yoshida M: Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm 1995, 46: 212-219.PubMed Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, Wakabayashi G, Niimi M, Taniguchi S, Yoshida M: Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm 1995, 46: 212-219.PubMed
4.
go back to reference Ruokonen E, Parviainen I, Uusaro A: Treatment of impaired perfusion in septic shock. Ann Med 2002, 34: 590-597. 10.1080/078538902321117814CrossRefPubMed Ruokonen E, Parviainen I, Uusaro A: Treatment of impaired perfusion in septic shock. Ann Med 2002, 34: 590-597. 10.1080/078538902321117814CrossRefPubMed
5.
go back to reference Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP: Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect 2003, 47: 300-306. 10.1016/S0163-4453(03)00101-4CrossRefPubMed Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP: Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect 2003, 47: 300-306. 10.1016/S0163-4453(03)00101-4CrossRefPubMed
6.
go back to reference Ridings PC, Windsor AC, Jutila MA, Blocher CR, Fisher BJ, Sholley MM, Sugerman HJ, Fowler AA III: A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med 1995, 152: 247-253.CrossRefPubMed Ridings PC, Windsor AC, Jutila MA, Blocher CR, Fisher BJ, Sholley MM, Sugerman HJ, Fowler AA III: A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med 1995, 152: 247-253.CrossRefPubMed
7.
go back to reference Carlos TM, Harlan JM: Leukocyte–endothelial adhesion molecules. Blood 1994, 84: 2068-2101.PubMed Carlos TM, Harlan JM: Leukocyte–endothelial adhesion molecules. Blood 1994, 84: 2068-2101.PubMed
8.
go back to reference Spies C, Haude V, Fitzner R, Schroder K, Overbeck M, Runkel N, Schaffartzik W: Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113: 1055-1063.CrossRefPubMed Spies C, Haude V, Fitzner R, Schroder K, Overbeck M, Runkel N, Schaffartzik W: Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113: 1055-1063.CrossRefPubMed
9.
go back to reference Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE: Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 1996, 24: 1782-1786. 10.1097/00003246-199611000-00004CrossRefPubMed Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE: Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 1996, 24: 1782-1786. 10.1097/00003246-199611000-00004CrossRefPubMed
10.
go back to reference Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J: Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998, 157: 776-784.CrossRefPubMed Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J: Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998, 157: 776-784.CrossRefPubMed
11.
go back to reference Boldt J, Muller M, Kuhn D, Linke LC, Hempelmann G: Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996, 22: 122-128.CrossRefPubMed Boldt J, Muller M, Kuhn D, Linke LC, Hempelmann G: Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996, 22: 122-128.CrossRefPubMed
12.
go back to reference Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, Fowler AA III: Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 1995, 151: 1420-1427.CrossRefPubMed Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, Fowler AA III: Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 1995, 151: 1420-1427.CrossRefPubMed
13.
go back to reference Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, Frass M, Graninger W: Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997, 156: 825-832.CrossRefPubMed Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, Frass M, Graninger W: Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997, 156: 825-832.CrossRefPubMed
14.
go back to reference Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991, 91: 23-29. 10.1016/0002-9343(91)90069-ACrossRefPubMed Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991, 91: 23-29. 10.1016/0002-9343(91)90069-ACrossRefPubMed
15.
go back to reference Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL: Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997, 25: 1813-1819. 10.1097/00003246-199711000-00018CrossRefPubMed Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL: Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997, 25: 1813-1819. 10.1097/00003246-199711000-00018CrossRefPubMed
16.
go back to reference Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed
17.
go back to reference Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103: 565-575.CrossRefPubMed Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103: 565-575.CrossRefPubMed
18.
go back to reference Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 1994, 22: 651-657.CrossRefPubMed Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 1994, 22: 651-657.CrossRefPubMed
19.
go back to reference Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990, 161: 982-987.CrossRefPubMed Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990, 161: 982-987.CrossRefPubMed
20.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655.CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655.CrossRefPubMed
21.
go back to reference Bennett JA, Riegel B, Bittner V, Nichols J: Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 2002, 31: 262-270. 10.1067/mhl.2002.124554CrossRefPubMed Bennett JA, Riegel B, Bittner V, Nichols J: Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 2002, 31: 262-270. 10.1067/mhl.2002.124554CrossRefPubMed
22.
go back to reference Spies CD, Kern H, Schroder T, Sander M, Sepold H, Lang P, Stangl K, Behrens S, Sinha P, Schaffartzik W, et al.: Myocardial ischemia and cytokine response are associated with subsequent onset of infections after noncardiac surgery. Anesth Analg 2002, 95: 9-18. table 10.1097/00000539-200207000-00002CrossRefPubMed Spies CD, Kern H, Schroder T, Sander M, Sepold H, Lang P, Stangl K, Behrens S, Sinha P, Schaffartzik W, et al.: Myocardial ischemia and cytokine response are associated with subsequent onset of infections after noncardiac surgery. Anesth Analg 2002, 95: 9-18. table 10.1097/00000539-200207000-00002CrossRefPubMed
23.
go back to reference Kox WJ, Spies C: Ckeck-up Anästhesiologie. Standards. -Anästhesie, -Intensivmedizin, -Schmerztherapie, -Notfallmedizin. Berlin: Springer Verlag; 2003. Kox WJ, Spies C: Ckeck-up Anästhesiologie. Standards. -Anästhesie, -Intensivmedizin, -Schmerztherapie, -Notfallmedizin. Berlin: Springer Verlag; 2003.
24.
go back to reference Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA III: Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997, 156: 431-437.CrossRefPubMed Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA III: Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997, 156: 431-437.CrossRefPubMed
25.
go back to reference Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997, 18: 428-432. 10.1016/S0167-5699(97)01103-1CrossRefPubMed Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997, 18: 428-432. 10.1016/S0167-5699(97)01103-1CrossRefPubMed
26.
go back to reference Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83: 113-118.PubMed Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83: 113-118.PubMed
27.
go back to reference Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G: Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 2002, 30: 1987-1994. 10.1097/00003246-200209000-00007CrossRefPubMed Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G: Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 2002, 30: 1987-1994. 10.1097/00003246-200209000-00007CrossRefPubMed
28.
go back to reference Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992, 215: 356-362.PubMedCentralCrossRefPubMed Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992, 215: 356-362.PubMedCentralCrossRefPubMed
29.
go back to reference Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D: Cytokine cascade in sepsis. Scand J Infect Dis 2003, 35: 535-544. 10.1080/00365540310015935CrossRefPubMed Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D: Cytokine cascade in sepsis. Scand J Infect Dis 2003, 35: 535-544. 10.1080/00365540310015935CrossRefPubMed
30.
go back to reference Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994, 22: 673-679.CrossRefPubMed Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994, 22: 673-679.CrossRefPubMed
31.
go back to reference Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992, 60: 2835-2842.PubMedCentralPubMed Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992, 60: 2835-2842.PubMedCentralPubMed
32.
go back to reference Endo S, Inada K, Ceska M, Takakuwa T, Yamada Y, Nakae H, Kasai T, Yamashita H, Taki K, Yoshida M: Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflamm 1995, 45: 136-142.PubMed Endo S, Inada K, Ceska M, Takakuwa T, Yamada Y, Nakae H, Kasai T, Yamashita H, Taki K, Yoshida M: Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflamm 1995, 45: 136-142.PubMed
33.
go back to reference Muehlstedt SG, Richardson CJ, West MA, Lyte M, Rodriguez JL: Cytokines and the pathogenesis of nosocomial pneumonia. Surgery 2001, 130: 602-609. 10.1067/msy.2001.117105CrossRefPubMed Muehlstedt SG, Richardson CJ, West MA, Lyte M, Rodriguez JL: Cytokines and the pathogenesis of nosocomial pneumonia. Surgery 2001, 130: 602-609. 10.1067/msy.2001.117105CrossRefPubMed
34.
go back to reference Franz AR, Steinbach G, Kron M, Pohlandt F: Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants. Acta Paediatr 2001, 90: 1025-1032. 10.1080/080352501316978110CrossRefPubMed Franz AR, Steinbach G, Kron M, Pohlandt F: Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants. Acta Paediatr 2001, 90: 1025-1032. 10.1080/080352501316978110CrossRefPubMed
35.
go back to reference Dembinski J, Behrendt D, Heep A, Dorn C, Reinsberg J, Bartmann P: Cell-associated interleukin-8 in cord blood of term and preterm infants. Clin Diagn Lab Immunol 2002, 9: 320-323. 10.1128/CDLI.9.2.320-323.2002PubMedCentralPubMed Dembinski J, Behrendt D, Heep A, Dorn C, Reinsberg J, Bartmann P: Cell-associated interleukin-8 in cord blood of term and preterm infants. Clin Diagn Lab Immunol 2002, 9: 320-323. 10.1128/CDLI.9.2.320-323.2002PubMedCentralPubMed
36.
go back to reference Lin KJ, Lin J, Hanasawa K, Tani T, Kodama M: Interleukin-8 as a predictor of the severity of bacteremia and infectious disease. Shock 2000, 14: 95-100.CrossRefPubMed Lin KJ, Lin J, Hanasawa K, Tani T, Kodama M: Interleukin-8 as a predictor of the severity of bacteremia and infectious disease. Shock 2000, 14: 95-100.CrossRefPubMed
37.
go back to reference Martin C, Viviand X, Leone M, Thirion X: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000, 28: 2758-2765. 10.1097/00003246-200008000-00012CrossRefPubMed Martin C, Viviand X, Leone M, Thirion X: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000, 28: 2758-2765. 10.1097/00003246-200008000-00012CrossRefPubMed
38.
go back to reference Hayes MA, Timmins AC, Yau EH, Palazzo M, Watson D, Hinds CJ: Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med 1997, 25: 926-936. 10.1097/00003246-199706000-00007CrossRefPubMed Hayes MA, Timmins AC, Yau EH, Palazzo M, Watson D, Hinds CJ: Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med 1997, 25: 926-936. 10.1097/00003246-199706000-00007CrossRefPubMed
39.
go back to reference Hinds C, Watson D: Manipulating hemodynamics and oxygen transport in critically ill patients. N Engl J Med 1995, 333: 1074-1075. 10.1056/NEJM199510193331609CrossRefPubMed Hinds C, Watson D: Manipulating hemodynamics and oxygen transport in critically ill patients. N Engl J Med 1995, 333: 1074-1075. 10.1056/NEJM199510193331609CrossRefPubMed
40.
go back to reference Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995, 333: 1025-1032. 10.1056/NEJM199510193331601CrossRefPubMed Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995, 333: 1025-1032. 10.1056/NEJM199510193331601CrossRefPubMed
41.
go back to reference Goncalves JA Jr, Hydo LJ, Barie PS: Factors influencing outcome of prolonged norepinephrine therapy for shock in critical surgical illness. Shock 1998, 10: 231-236.CrossRefPubMed Goncalves JA Jr, Hydo LJ, Barie PS: Factors influencing outcome of prolonged norepinephrine therapy for shock in critical surgical illness. Shock 1998, 10: 231-236.CrossRefPubMed
42.
go back to reference Krishnagopalan S, Kumar A, Parrillo JE, Kumar A: Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002, 8: 376-388. 10.1097/00075198-200210000-00003CrossRefPubMed Krishnagopalan S, Kumar A, Parrillo JE, Kumar A: Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002, 8: 376-388. 10.1097/00075198-200210000-00003CrossRefPubMed
43.
go back to reference Boldt J, Muller M, Heesen M, Papsdorf M, Hempelmann G: Does age influence circulating adhesion molecules in the critically ill? Crit Care Med 1997, 25: 95-100. 10.1097/00003246-199701000-00019CrossRefPubMed Boldt J, Muller M, Heesen M, Papsdorf M, Hempelmann G: Does age influence circulating adhesion molecules in the critically ill? Crit Care Med 1997, 25: 95-100. 10.1097/00003246-199701000-00019CrossRefPubMed
Metadata
Title
Time course of endothelial damage in septic shock: prediction of outcome
Authors
Ortrud Vargas Hein
Klaudia Misterek
Jan-Peer Tessmann
Vera van Dossow
Michael Krimphove
Claudia Spies
Publication date
01-08-2005
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2005
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3532

Other articles of this Issue 4/2005

Critical Care 4/2005 Go to the issue